» Articles » PMID: 35051205

Clinical Characteristics and Histopathology of COVID-19 Related Deaths in South African Adults

Abstract

Comparisons of histopathological features and microbiological findings between decedents with respiratory symptoms due to SARS-CoV-2 infection or other causes, in settings with high prevalence of HIV and Mycobacterium tuberculosis (MTB) infections have not been reported. Deaths associated with a positive ante-mortem SARS-CoV-2 PCR test and/or respiratory disease symptoms at Chris Hani Baragwanath Academic Hospital in Soweto, South Africa from 15th April to 2nd November 2020, during the first wave of the South African COVID-19 epidemic, were investigated. Deceased adult patients had post-mortem minimally-invasive tissue sampling (MITS) performed to investigate for SARS-CoV-2 infection and molecular detection of putative pathogens on blood and lung samples, and histopathology examination of lung, liver and heart tissue. During the study period MITS were done in patients displaying symptoms of respiratory disease including 75 COVID-19-related deaths (COVID+) and 42 non-COVID-19-related deaths (COVID-). The prevalence of HIV-infection was lower in COVID+ (27%) than in the COVID- (64%), MTB detection was also less common among COVID+ (3% vs 13%). Lung histopathology findings showed differences between COVID+ and COVID- in the severity of the morphological appearance of Type-II pneumocytes, alveolar injury and repair initiated by SARS-CoV-2 infection. In the liver necrotising granulomatous inflammation was more common among COVID+. No differences were found in heart analyses. The prevalence of bacterial co-infections was higher in COVID+. Most indicators of respiratory distress syndrome were undifferentiated between COVID+ and COVID- except for Type-II pneumocytes. HIV or MTB infection does not appear in these data to have a meaningful correspondence with COVID-related deaths.

Citing Articles

Etiology and antimicrobial susceptibility patterns of bacteria causing pneumonia among adult patients with signs and symptoms of lower respiratory tract infections during the COVID-19 pandemic in Mwanza, Tanzania: a cross-sectional study.

Rukyaa J, Mushi M, Silago V, Damiano P, Keenan K, Sabiiti W Pneumonia (Nathan). 2024; 16(1):16.

PMID: 39232828 PMC: 11375869. DOI: 10.1186/s41479-024-00137-9.


Cardio-Pulmonary Histopathology with Clinical Correlations of Deceased Patients with COVID-19: A Case Series in Tehran, Iran.

Soleiman-Meigooni S, Yaghmayee R, Mohammadi S, Ahmadi M, Sakhabakhsh M, Hamidi-Farahani R Arch Iran Med. 2024; 26(5):252-260.

PMID: 38301088 PMC: 10685862. DOI: 10.34172/aim.2023.39.


Differential activation of programmed cell death in patients with severe SARS-CoV-2 infection.

Riegler A, Benson P, Long K, Leal Jr S Cell Death Discov. 2023; 9(1):420.

PMID: 37985756 PMC: 10662024. DOI: 10.1038/s41420-023-01715-4.


Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort.

Shaw J, Meiring M, Snyders C, Everson F, Sigwadhi L, Ngah V Front Immunol. 2023; 14:1219097.

PMID: 37465683 PMC: 10351604. DOI: 10.3389/fimmu.2023.1219097.


The Spectrum of Digestive Tract Histopathologic Findings in the Setting of Severe Acute Respiratory Syndrome Coronavirus-2 Infection: What Pathologists Need to Know.

Al-Zaidi R Adv Anat Pathol. 2023; .

PMID: 37015261 PMC: 10412085. DOI: 10.1097/PAP.0000000000000398.


References
1.
Solarino B, Ferorelli D, DellErba A . Post-mortem routine practice in the era of the COVID-19 pandemic. J Forensic Leg Med. 2020; 74:102010. PMC: 7836613. DOI: 10.1016/j.jflm.2020.102010. View

2.
Polak S, Van Gool I, Cohen D, von der Thusen J, van Paassen J . A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol. 2020; 33(11):2128-2138. PMC: 7306927. DOI: 10.1038/s41379-020-0603-3. View

3.
Attoh S, Segborwotso R, Akoriyea S, Teddy G, Edusei L, Hobenu F . COVID-19 autopsy reports from the Ga-East Municipal and the 37 Military Hospitals in Accra, Ghana. Ghana Med J. 2021; 54(4 Suppl):52-61. PMC: 8087362. DOI: 10.4314/gmj.v54i4s.9. View

4.
Menter T, Haslbauer J, Nienhold R, Savic S, Hopfer H, Deigendesch N . Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020; 77(2):198-209. PMC: 7496150. DOI: 10.1111/his.14134. View

5.
Kaarteenaho R, Kinnula V . Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders. Pulm Med. 2011; 2011:531302. PMC: 3099744. DOI: 10.1155/2011/531302. View